| Website | genzyme.com |
| Phone | 617 252 7500 |
| Employees |
Genzyme Ventures is a corporate venture capital fund dedicated to helping Genzyme Corporation achieve its strategic goals. Founded in 2001, the $100 million fund has a current portfolio of direct corporate investments and has taken LP positions in funds managed by life-science focused VC firms. Through its direct investments in private early-stage companies, the fund aims to forge relationships which may lead to larger collaborations in the future. Genzyme Ventures is able to leverage the entire Genzyme organization, including its global experience and expertise in R&D, reimbursement, and commercialization, to provide portfolio companies with invaluable advice and assistance. Its Limited Partnership investments provide insight into the broader healthcare innovation landscape.
| Company | Date | Round | Size | Participants |
| KaloBios Pharmaceuticals | 12/08 | Series D | $12M | 8 |
| Proteostasis Therapeutics | 8/08 | Series A | $45M | 5 |
| Sirtris Pharmaceuticals | 4/06 | Series C | $37M | 2 |
